← Back to Search

DPP Program for Prediabetes

N/A
Waitlist Available
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial aims to improve the health of Penn State patients with pre-diabetes and also decrease the costs associated with type 2 diabetes and its complications.

Eligible Conditions
  • Prediabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subject Retention
Weight Loss
Secondary outcome measures
A1c
Blood Pressure
Knee Injury and Osteoarthritis Outcome Score (KOOS)
+4 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Treatment 3 Motivational Text MessagingExperimental Treatment2 Interventions
This group will receive text messages with motivational messages while participating in the PSH DPP program. There will be two cohorts for this arm.
Group II: Treatment 2 Financial Incentives BExperimental Treatment2 Interventions
This group will receive gift cards as financial incentive to participate in the PSH DPP program. There will be two cohorts for this arm.
Group III: Treatment 1 Financial Incentives AExperimental Treatment2 Interventions
This group will receive gift cards as financial incentive to participate in the PSH DPP program. There will be two cohorts for this arm.
Group IV: Control PSH DPP onlyActive Control1 Intervention
This group will be enrolled the PSH DPP program. There will be two cohorts for this arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Financial Incentives
2018
Completed Phase 2
~11460
Motivational Message
2021
N/A
~30
DPP Program
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterOTHER
492 Previous Clinical Trials
2,798,792 Total Patients Enrolled
Penn State UniversityLead Sponsor
355 Previous Clinical Trials
125,727 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment in progress and open to new participants?

"Clinicaltrials.gov information reveals that registration for this clinical trial has ceased; the study was first published on May 25th 2021 and its last update occurred October 7th 2022. Although enrollment is not possible at present, there are 1291 other medical studies currently recruiting patients."

Answered by AI

What are the eligibility criteria for joining this experiment?

"This clinical trial seeks 30 participants, aged between 18 and 64, who have been diagnosed with diabetes mellitus. Additional requirements must be fulfilled by potential enrollees: they should not be pregnant during the time of enrollment; they can't have a pre-existing diagnosis of either type 1 or 2 diabetes; need to maintain an active patient status at Penn State Health clinic in Pennsylvania (at least one visit within the last 18 months); own either an iPhone running iOS 10+ or Android 7+ smartphone which is carried during waking hours; possess internet access for data collection purposes; present with BMI ≥25 kg/m2 (or 23 kg/m"

Answered by AI

Are adults of legal age able to participate in this research study?

"Eligibility for this specific trial requires potential participants to fall within the 18-64 age range. In contrast, there are separate medical trials tailored towards those younger than 18 (188 trials) and seniors above 65 years old (973)."

Answered by AI

What ultimate goal is this clinical experiment hoping to accomplish?

"The primary objective of the trial, which will be monitored for a year's duration is to assess Weight loss. There are also three secondary goals which include tracking Blood Pressure through regular readings, measuring A1c levels throughout the research period and assessing Quality of Life (SF-36) using surveys."

Answered by AI
~8 spots leftby Apr 2025